European Oxygen Therapy Devices Market was worth USD 0.50
billion in 2016 and estimated to be growing at a CAGR of 5.77%, to reach USD
0.67 billion by 2021. Oxygen therapy involves administering oxygen through an
external device. COPD includes chronic obstructive bronchitis and emphysema,
and is predicted by the World Health Organization (WHO) to be the fourth
leading cause of death worldwide by 2030.
Oxygen Therapy devices are useful specially for people suffering
from severe COPD or cystic fibrosis who suffer from chronically low oxygen
levels in their body. Advantages of oxygen therapy also include increased
mental stamina, aversion of heart failure, and an enhanced breathing pattern.
The administration and supply of supplementary oxygen have turned into an
indispensable part in the management of numerous diseases. Furthermore, oxygen
therapy is applicable to numerous diseases, for example, asthma, respiratory
distress syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in
patients suffering from chronic lung disease are believed to enhance the length
and the quality of life.
View Full Report: http://marketdataforecast.com/market-reports/europe-oxygen-therapy-market-3690/
In Europe, the prevalence of COPD varies markedly across
countries. For example, the Ministère de la Santé et des Solidaritiés estimates
that between 6% and 8% of the adult population in France suffers from COPD.
Interestingly, the Netherlands displays just a 2% prevalence rate as evaluated
by the National Institute for Public Health and the Environment. Generally,
these devices are used to treat patients who are no longer able to receive
adequate volumes of oxygen through the breathing of natural air and require
higher concentrations of oxygen. A significant increase is expected in the
number of patients on oxygen therapy as the population ages and as members of
the 50 to 75 age demographics, who were often smokers in their youth, develop
emphysema and related conditions. It is estimated that over 85% of the patients
on oxygen therapy are, or were, once smokers.
Request for Sample Brochure: http://marketdataforecast.com/market-reports/europe-oxygen-therapy-market-3690/request-sample
The European oxygen therapy devices market is segmented into
product type, application and end user. On the basis of product, it is
segmented into Oxygen Source Equipment, Cylinders, Concentrators, Liquid Oxygen
Devices, PAP, Oxygen Delivery Device, Masks, Nasal Cannula, Venturi Mask, Non-Rebreather
Mask, Bag Valve and CPAP. Oxygen source equipment are expected to grow at 11%
CAGR It is attributed to the consolidation of this equipment in the extensive
variety of uses as the first line of treatment. On the basis of application, it
is segmented into Chronic Obstructive Pulmonary Disease, Asthma, Obstructive
Sleep Apnoea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia.
Chronic obstructive pulmonary disease holds the largest share of the
application segment and it is anticipated to grow lucratively at a CAGR of over
10.5% over the next five years. This is due to increasing popularity of
supplemental administration in conjunction with first line treatments available
for COPD. Moreover, this treatment includes faster response rates, reliability
and portability, and above all improves chances of survival. On the basis of
end use it is segmented into Home Healthcare and Hospitals. Home health care
dominates the end-use segment, owing to the rise in elderly population coupled
with increasing number of patients with low mobility and long-term care
requirement in conditions such as Alzheimer’s disease.
Inquire
Before Buying: http://marketdataforecast.com/market-reports/europe-oxygen-therapy-market-3690/inquire
The European region is geographically segmented into Germany,
U.K, Italy, Spain and France. Europe has the second highest revenue in the
oxygen therapy devices market and is expected to grow further in the coming
years. Favourable government policies and initiatives such as European
Committee for Hyperbaric Medicine (ECHM), involved in promoting awareness
pertaining to the treatment and thereby promoting growth of oxygen therapy devices
market.
·
Market Segmentation
·
Product
·
5.1.1 Introduction
·
5.1.2 Oxygen Source
Equipment
·
5.1.2.1 Oxygen
Concentrators
·
5.1.2.1.1 Fixed Oxygen
Concentrators
·
5.1.2.1.2 Portable
Oxygen Concentrators
·
5.1.2.2 Liquid Oxygen
Devices
·
5.1.2.3 Oxygen
Cylinders
·
5.1.3 Oxygen Delivery
Devices
·
5.1.3.1 Oxygen Masks
·
5.1.3.2 Nasal Cannulas
·
5.1.3.3 Venturi Masks
·
5.1.3.4 Non-Rebreather
Masks
·
5.1.3.5 Bag Valve
Masks
·
5.1.3.6 Other Devices
·
5.1.4 Y-o-Y
Growth Analysis, By Product
·
5.1.5 Market
Attractiveness Analysis, By Product
·
5.1.6 Market
Share Analysis, By Product
·
Portability
·
5.2.1 Introduction
·
5.2.2 Stationary
Oxygen Therapy Devices
·
5.2.3 Portable Oxygen
Therapy Devices
·
5.2.4 Y-o-Y Growth
Analysis, By Portability
·
5.2.5 Market
Attractiveness Analysis, By Portability
·
5.2.6 Market Share
Analysis, By Portability
·
Application
·
5.3.1 Introduction
·
5.3.2 Chronic
Obstructive Pulmonary Disease
·
5.3.3 Asthma,
Obstructive Sleep Apnea
·
5.3.4 Respiratory
Distress Syndrome
·
5.3.5 Cystic Fibrosis
·
5.3.6 Pneumonia
·
5.3.7 Y-o-Y Growth
Analysis, By Application
·
5.3.8 Market
Attractiveness Analysis, By Application
·
5.3.9 Market
Share Analysis, By Application
·
End User
·
5.4.1 Introduction
·
5.4.2 Home Care
Settings
·
5.4.3 Hospitals
·
5.4.4 Ambulatory
Surgical Centers & Physician Offices
·
5.4.5 Others
·
5.4.6 Y-o-Y Growth
Analysis, By End User
·
5.4.7 Market
Attractiveness Analysis, By End User
·
5.4.8 Market Share
Analysis, By End User
This market is extremely disjointed with numerous big and
developing players operating in the business. The major companies dominating
the oxygen therapy devices market in this region are Philips Respironics,
ResMed, GEHealthcare, Dräger, Medtronic – Covidien, Teleflex Medical, Fisher
& Paykel, Invacare, Smiths Medical, Ambu – King, Carefusion – BD,
Intersurgical, Maquet, Flexicare, PARI, Breas, DeVilbiss – Drive, Mindray and
AirSep.
About Us:
Market Data Forecast is a firm working in the area of market
research and business intelligence. With rich experience in research across
various business domains, we cater to the needs of both individual and
corporate clients. Our analyst team comprises expert professionals in market
research, who with their collective knowledge and sksillset dedicatedly serve
clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
